Cargando…
A Pan-Cancer Landscape of ABCG2 across Human Cancers: Friend or Foe?
Emerging evidence from research or clinical studies reported that ABCG2 (ATP-binding cassette sub-family G member 2) interrelates with multidrug resistance (MDR) development in cancers. However, no comprehensive pan-cancer analysis is available at present. Therefore, we explore multiple databases, s...
Autores principales: | Lyu, Chen, Wang, Lili, Stadlbauer, Birgit, Buchner, Alexander, Pohla, Heike |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784838/ https://www.ncbi.nlm.nih.gov/pubmed/36555598 http://dx.doi.org/10.3390/ijms232415955 |
Ejemplares similares
-
Identification of EZH2 as Cancer Stem Cell Marker in Clear Cell Renal Cell Carcinoma and the Anti-Tumor Effect of Epigallocatechin-3-Gallate (EGCG)
por: Lyu, Chen, et al.
Publicado: (2022) -
Identification of a novel combination treatment strategy in clear cell renal cell carcinoma stem cells with shikonin and ipilimumab
por: Lyu, Chen, et al.
Publicado: (2023) -
Diagnostic and Prognostic Role of miR-192 in Different Cancers: A Systematic Review and Meta-Analysis
por: Wang, Lili, et al.
Publicado: (2021) -
An integrated multi-omics analysis of topoisomerase family in pan-cancer: Friend or foe?
por: Zhou, Xin, et al.
Publicado: (2022) -
Integrative Analysis of MUC4 to Prognosis and Immune Infiltration in Pan-Cancer: Friend or Foe?
por: Gao, Xiao-Peng, et al.
Publicado: (2021)